Risks of blood transfusion
- 1 December 2003
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 31 (Supplement), S678-S686
- https://doi.org/10.1097/01.ccm.0000100124.50579.d9
Abstract
To review the current status of risks of blood transfusion. English-speaking literature, literature search using key works, human data, and follow-up with key bibliographic citations. Substantial advances have been achieved in blood safety during the last 20 yrs, particularly for transfusion-transmitted viral infections. Currently, the most serious known risks from blood transfusion are administrative error (leading to ABO-incompatible blood transfusion), transfusion-related acute lung injury, and bacterial contamination in platelet products. Emerging pathogens, such as West Nile virus infection emphasize the need for implementation of proactive strategies, such as pathogen inactivation technologies, as well as reactive strategies, such as nucleic acid testing, to ensure continued advances in blood safety.Keywords
This publication has 89 references indexed in Scilit:
- Evaluation of an automated culture systemfor detecting bacterial contamination of platelets: an analysis with 15 contaminating organismsTransfusion, 2001
- Adult T-Cell Leukemia with HTLV-I–Associated Myelopathy after Complete Remission of Acute Myelogenous LeukemiaNew England Journal of Medicine, 1998
- The Role of the Plasma from Platelet Concentrates in Transfusion ReactionsNew England Journal of Medicine, 1994
- Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancerThe Lancet, 1994
- Rapid Development of Myelopathy after HTLV-I Infection Acquired by Transfusion during Cardiac TransplantationNew England Journal of Medicine, 1990
- Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1989
- Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow TransplantationNew England Journal of Medicine, 1986
- Diagnostic and pathogenetic considerations in transfusion‐related acute lung injuryTransfusion, 1985
- Serum Alanine Aminotransferase of Donors in Relation to the Risk of Non-A,Non-B Hepatitis in RecipientsNew England Journal of Medicine, 1981
- Improvement of Kidney-Graft Survival with Increased Numbers of Blood TransfusionsNew England Journal of Medicine, 1978